Longeveron Inc. (LGVN)
NASDAQ: LGVN · IEX Real-Time Price · USD
1.280
-0.010 (-0.78%)
May 17, 2024, 4:00 PM EDT - Market closed
Longeveron Market Cap
Longeveron has a market cap or net worth of $8.03 million as of May 17, 2024. Its market cap has decreased by -88.93% in one year.
Market Cap
8.03M
Enterprise Value
7.64M
1-Year Change
-88.93%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $8.03M, a decrease of -95.34%. That is a compound annual growth rate of -60.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 8.10M | -1.22% |
| May 16, 2024 | 8.20M | -3.53% |
| May 15, 2024 | 8.50M | -3.41% |
| May 14, 2024 | 8.80M | 166.67% |
| May 13, 2024 | 3.30M | -10.81% |
| May 10, 2024 | 3.70M | -5.13% |
| May 9, 2024 | 3.90M | -7.14% |
| May 8, 2024 | 4.20M | - |
| May 7, 2024 | 4.20M | - |
| May 6, 2024 | 4.20M | -4.55% |
| May 3, 2024 | 4.40M | -2.22% |
| May 2, 2024 | 4.50M | 2.27% |
| May 1, 2024 | 4.40M | 2.33% |
| Apr 30, 2024 | 4.30M | 2.38% |
| Apr 29, 2024 | 4.20M | -4.55% |
| Apr 26, 2024 | 4.40M | 4.76% |
| Apr 25, 2024 | 4.20M | -2.33% |
| Apr 24, 2024 | 4.30M | -6.52% |
| Apr 23, 2024 | 4.60M | -2.13% |
| Apr 22, 2024 | 4.70M | -2.08% |
| Apr 19, 2024 | 4.80M | -5.88% |
| Apr 18, 2024 | 5.10M | -3.77% |
| Apr 17, 2024 | 5.30M | -40.45% |
| Apr 16, 2024 | 8.90M | 20.27% |
| Apr 15, 2024 | 7.40M | 76.19% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MIRA Pharmaceuticals | 9.33M |
| Notable Labs | 9.20M |
| eFFECTOR Therapeutics | 9.17M |
| Novo Integrated Sciences | 9.17M |
| BioRestorative Therapies | 9.14M |
| NeuroMetrix | 8.11M |
| Kintara Therapeutics | 7.90M |
| Vaccinex | 7.89M |